![DAPSONE 6% / NIACINAMIDE 2% / TRETINOIN 0.025% GEL [SINCERUS FLORIDA, LLC]](https://medic.hrt.org//dailymed/images/88011b04-0617-48ad-e053-2a95a90aa384/-2 end.jpg)
![DAPSONE 6% / NIACINAMIDE 2% / TRETINOIN 0.025% GEL [SINCERUS FLORIDA, LLC]](https://medic.hrt.org//dailymed/images/88011b04-0617-48ad-e053-2a95a90aa384/1062- middle.jpg)
![DAPSONE 6% / NIACINAMIDE 2% / TRETINOIN 0.025% GEL [SINCERUS FLORIDA, LLC]](https://medic.hrt.org//dailymed/images/88011b04-0617-48ad-e053-2a95a90aa384/1062-2 front.jpg)
- Directions for Use
- Sincerus Flroida, LLC, adverse reactions
- Active, Inactive
- NDC 72934-1062-2. DAPSONE USP 6%/ NIACINAMIDE USP 2% / TRETINOIN USP 0.025%. Gel30gm.
-
INGREDIENTS AND APPEARANCE
DAPSONE 6% / NIACINAMIDE 2% / TRETINOIN 0.025%
dapsone 6% / niacinamide 2% / tretinoin 0.025% gelProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72934-1062 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE 2 g in 100 g DAPSONE (UNII: 8W5C518302) (DAPSONE - UNII:8W5C518302) DAPSONE 6 g in 100 g TRETINOIN (UNII: 5688UTC01R) (TRETINOIN - UNII:5688UTC01R) TRETINOIN 0.025 g in 100 g Product Characteristics Color yellow Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:72934-1062-2 30 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product 05/04/2019 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 05/04/2019 Labeler - Sincerus Florida, LLC (080105003) Establishment Name Address ID/FEI Business Operations Sincerus Florida, LLC 080105003 manufacture(72934-1062)
